Venous Stents Market to exceed US$ 2 Billion by 2027 Globally |CAGR: 9%| UnivDatos Market Insights
NOIDA, India, July 9, 2021 /PRNewswire/ -- A comprehensive overview of the Venous Stents market is recently added by UnivDatos Market Insights to its humongous database. The Venous Stents market report has been aggregated by collecting informative data from various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Venous Stents market. The Venous Stents market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Venous Stents market at the global and regional levels. Venous Stents market is expected to grow at a CAGR of 9% from 2021-2027 to exceed US$ 2 billion by 2027.
Request Sample Copy of this Report @ https://bit.ly/3hGU7Wo
Vascular disorders are more prevalent in developed countries as compared to the economically weaker countries mostly because of the lifestyle differences in the two communities. The rise of venous diseases such as post-thrombotic syndrome, chronic deep vein thrombosis, May-Thurner syndrome, Hemodialysis/arteriovenous fistulae, nutcracker syndrome etc. play a huge role in the growth of venous stents market. According to the center for disease control and prevention, 60,000-100,000 individuals in the US die from deep vein thrombosis every year. Venous stents can help cure these diseases. The prevalence of vascular diseases is constantly rising boosting the market growth. Major constraints in the market include the lack of awareness and high cost associated with stenting.
Before the pandemic vascular disease treatments could be elective, urgent, and emergent in nature. Elective Procedures performed routinely also included venous stenting. Urgent and emergent cases combined with nonelective arterial disease comprise of approximately 30%-50% of vascular surgery practices. The timelines and efficacy of care was disrupted due to the pandemic. Physicians were under the dilemma of calling patients to hospital due to the potential Covid-19 exposure. Even the outpatient vascular services and office-based laboratories were severely affected mostly for elective venous treatments. In a global survey consudted by ng et al., vascular surgeons reported an 86.9% downscale or suspension of services due to the pandemic.
Ask for Price & Discounts @ https://bit.ly/3hGU7Wo
Venous Stents market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.
By Technology, the market is primarily segmented into
- Illiac Vein Stent Technology
- Wallstent Technology
The Wallstent segment was valued at US$ XX million in 2020 and is likely to reach US$ XX million by 2027 growing at a CAGR of XX% from 2021-2027.
By Application, the market is primarily segmented into
The Legs segment was valued at US$ XX million in 2020 and is likely to reach US$ XX million by 2027 growing at a CAGR of XX% from 2021-2027.
By Disease, the market is primarily segmented into
- Chronic Deep Vein Thrombosis
- Post Thrombotic Syndrome
The Chronic Deep Vein Thrombosis segment was valued at US$ XX million in 2020 and is likely to reach US$ XX million by 2027 growing at a CAGR of XX% from 2021-2027.
Venous Stents Market Geographical Segmentation Includes:
- North America (the U.S, Canada, and Rest of North America)
- Europe (Germany, France, Spain, Italy, UK, and Rest of Europe)
- Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific)
- Rest of the World
Based on the estimation, the North America region dominated the Venous Stents market with almost XX% revenue share in 2020.
Ask for Report Customization @ https://bit.ly/3hGU7Wo
The major players targeting the market includes
- Boston Scientific Corporation
- Medtronic Plc
- Becton, Dickinson and Company
- Medica Germany GMBH & Co. KG
- Cook Medical
- W. L. Gore & Associates, Inc.
- Jotec GmBH
- Abbott Laboratories
- Optimed Medizinische Instrumente GmBH
- MOCHER GmbH
The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the Venous Stents market. The leading players have been analyzed by using research methodologies for getting insight views on global competition.
Key questions resolved through this analytical market research report include:
- What are the latest trends, new patterns, and technological advancements in the Venous Stents market?
- Which factors are influencing the Venous Stents market over the forecast period?
- What are the global challenges, threats, and risks in the Venous Stents market?
- Which factors are propelling and restraining the Venous Stents market?
- What are the demanding global regions of the Venous Stents market?
- What will be the global market size in the upcoming years?
- What are the crucial market acquisition strategies and policies applied by global companies?
We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.
Request for full report-https://bit.ly/3hGU7Wo
About UnivDatos Market Insights
UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.
SOURCE UnivDatos Market Insights
Upcoming Life Sciences Events
- September 2021
- Vilnius: Life Sciences Baltics
- BioPharm America™ 2021
- Online & Oxford: BioForward 2021